Blood pressure levels and control in Italy: Comprehensive analysis of clinical data from 2000-2005 and 2005-2011 hypertension surveys

Journal of Human Hypertension

Volumn 29, Issue 11, 2015, Pages 696-701

  Tocci, G ^a,b   Ferrucci, A ^a   Pontremoli, R ^c   Ferri, C ^d   Rosei, E A ^e   Morganti, A ^f   Trimarco, B ^g   Mancia, G ^h   Borghi, C ⁱ   Volpe, M ^a,b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF L'AQUILA   (Italy)

^e SPEDALI CIVILI   (Italy)

^f San Giuseppe Hospital   (Italy)

^g UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^h UNIVERSITY OF MILAN   (Italy)

ⁱ UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR RISK; CLINICAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GENERAL PRACTITIONER; HEALTH SURVEY; HUMAN; HYPERTENSION; ITALY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; CLINICAL PRACTICE; DRUG EFFECTS; HEALTH CARE SURVEY; OBSERVATIONAL STUDY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; GUIDELINE ADHERENCE; HEALTH CARE SURVEYS; HUMANS; HYPERTENSION; ITALY; OBSERVATIONAL STUDIES AS TOPIC; PRACTICE GUIDELINES AS TOPIC; PRACTICE PATTERNS, PHYSICIANS'; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84943453347     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2015.4     Document Type: Article

References (25)

1. Whyte JL, Lapuerta P, L'Italien GJ, Franklin SS. The challenge of controlling systolic blood pressure: data from the National Health and Nutrition Examination Survey (NHANES III), 1988-1994. J Clin Hypertens (Greenwich) 2001; 3(4): 211-216
2. Kotseva K, Wood D, De Backer G, De Bacquer D, Pyorala K, Keil U. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil 2009; 16(2): 121-137
3. Dallongeville J, Banegas JR, Tubach F, Guallar E, Borghi C, Backer GD et al. Survey of physicians' practices in the control of cardiovascular risk factors: the EURIKA study. Eur J Prev Cardiol 2012; 19(3): 541-550
4. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364(9438): 937-952
5. Danaei G, Finucane MM, Lin JK, Singh GM, Paciorek CJ, Cowan MJ et al. National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants. Lancet 2011; 377(9765): 568-577
6. Chobanian AV. Shattuck Lecture. The hypertension paradox-more uncontrolled disease despite improved therapy. N Engl J Med 2009; 361(9): 878-887
7. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365(9455): 217-223
8. Volpe M. The changing role of hypertension societies: shifting gears in Italy. High Blood Press Cardiovasc Prev 2012; 19(1): 1-2
9. de Burgos-Lunar C, Jimenez-Garcia R, Salinero-Fort MA, Gomez-Campelo P, Gil A, Abanades-Herranz JC et al. Trends in hypertension prevalence, awareness, treatment and control in an adult type 2 diabetes Spanish population between 2003 and 2009. PLoS One 2014; 9(1): e86713
10. Bromfield SG, Bowling CB, Tanner RM, Peralta CA, Odden MC, Oparil S et al. Trends in hypertension prevalence, awareness, treatment, and control among US adults 80 years and older, 1988-2010. J Clin Hypertens (Greenwich) 2014; 16(4): 270-276
11. Corrao G, Parodi A, Zambon A, Heiman F, Filippi A, Cricelli C et al. Reduced discontinuation of antihypertensive treatment by two-drug combination as first step. Evidence from daily life practice. J Hypertens 2010; 28(7): 1584-1590
12. Corrao G, Zambon A, Parodi A, Poluzzi E, Baldi I, Merlino L et al. Discontinuation of and changes in drug therapy for hypertension among newly treated patients: a population-based study in Italy. J Hypertens 2008; 26(4): 819-824
13. Volpe M, Tocci G, Trimarco B, Rosei EA, Borghi C, Ambrosioni E et al. Blood pressure control in Italy: results of recent surveys on hypertension. J Hypertens 2007; 25(7): 1491-1498
14. Tocci G, Rosei EA, Ambrosioni E, Borghi C, Ferri C, Ferrucci A et al. Blood pressure control in Italy: analysis of clinical data from 2005-2011 surveys on hypertension. J Hypertens 2012; 30(6): 1065-1074
15. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21(5): 821-848
16. O'Brien E, Asmar R, Beilin L, Imai Y, Mancia G, Mengden T et al. Practice guidelines of the European Society of Hypertension for clinic, ambulatory and self blood pressure measurement. J Hypertens 2005; 23(4): 697-701
17. Thijs L, Celis H, Clement D, Gil-Extremera B, Kawecka-Jaszcz K, Mancia G et al. Conventional and ambulatory blood pressure measurement in older patients with isolated systolic hypertension: second progress report on the ambulatory blood pressure monitoring project in the Syst-Eur trial. Blood Press Monit 1996; 1(2): 95-103
18. Whitworth JA, World Health Organization ISoHWG. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21(11): 1983-1992
19. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007; 25(9): 1751-1762
20. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M et al. 2013ESH/ ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Blood pressure trend and control in Italy Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2013; 34(28): 2159-2219
21. Mancia G, Facchetti R, Bombelli M, Polo Friz H, Grassi G, Giannattasio C et al. Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population. Hypertension 2005; 45(6): 1072-1077
22. Volpe M, Tocci G, Avogaro A, Comaschi M, Corsini A, Cortese C et al. Global Cardiovascular Risk Assessment in Different Clinical Settings: Basal Results of the EFFECTUS (Evaluation of Final Feasible Effect of Control Training and Ultra-Sensitisation) Programme. High Blood Press Cardiovasc Prev 2009; 16(2): 55-63
23. Leoncini G, Viazzi F, Rosei EA, Ambrosioni E, Costa FV, Leonetti G et al. Chronic kidney disease in hypertension under specialist care: the I-DEMAND study. J Hypertens 2010; 28(1): 156-162
24. Volpe M, Rosei EA, Ambrosioni E, Cottone S, Cuspidi C, Borghi C et al. 2012consensus document of the Italian Society of Hypertension (SIIA): strategies to improve blood pressure control in Italy: from global cardiovascular risk stratification to combination therapy. High Blood Press Cardiovasc Prev 2013; 20(1): 45-52
25. Zanchetti A, Facchetti R, Cesana GC, Modena MG, Pirrelli A, Sega R. Menopauserelated blood pressure increase and its relationship to age and body mass index: the SIMONA epidemiological study. J Hypertens 2005; 23(12): 2269-2276